CTIX Discussion Topics 08/16/2014 19:29:59 $CTIX
Apparition:
I stand by that post and today's posts they are consistent.
60% overall response is very significant.
50% stable disease is very significant.
Stable disease is much much better than progressive disease.
Good luck and GOD bless,
George
One of the primary hopes of this late stage Kevtrin FDA study is to set the stage for later studies.
My belief is that after the next cohorts several later stage FDA and foreign studies will begin. Continuing the FDA phase 1 study will help set the dosage for the future studies.
We do know:
1.•Phase 1b or 1b/2 trial at University of Bologna for hematological cancers acute myelogenous leukemia is planned.
http://cellceutix.com/cellceutix-announces-a-...abewy.dpbs
2.Additional Phase 2 trial at BIDMC for renal cell carcinoma is being contemplated.
3. Beth Israel: Kevetrin is being reviewed for study as a treatment for melanoma
http://cellceutix.com/cellceutix-enters-into-...enal-cell-
carcinoma/#sthash.KAfktMfz.dpbs
Both above reported: http://cellceutix.com/wp-content/uploads/2012...0131-1.pdf
3. Kevetrin is being reviewed for study by MD Anderson as a potential new treatment for Lymphoma and Multiple Myeloma.
http://cellceutix.com/cellceutix-signs-materi...DT22l.dpbs
4.Cellceutix and Beth Israel are reviewing Kevetrin for study as a treatment for Retinoblastoma. CTIX believes that retinoblastoma would make an excellent candidate for a phase 2/3 trial once our present phase 1 trial is completed. It would qualify for a number of FDA programs (Orphan, Fast Track and Breakthrough) that can exponentially shrink development time, should clinical data support the current research. - See more at: http://cellceutix.com/cellceutix-plans-for-fu...xKFTM.dpuf
Tempered view huh.... Varies month to month.... History says it all.
georgejjl Saturday, 04/05/14 05:03:15 PM
Re: None
Apparition:
I stand by that post and today's posts they are consistent.
60% overall response is very significant.
50% stable disease is very significant.
Stable disease is much much better than progressive disease.
Good luck and GOD bless,
George
One of the primary hopes of this late stage Kevtrin FDA study is to set the stage for later studies.
My belief is that after the next cohorts several later stage FDA and foreign studies will begin. Continuing the FDA phase 1 study will help set the dosage for the future studies.
We do know:
1.•Phase 1b or 1b/2 trial at University of Bologna for hematological cancers acute myelogenous leukemia is planned.
http://cellceutix.com/cellceutix-announces-a-...abewy.dpbs
2.Additional Phase 2 trial at BIDMC for renal cell carcinoma is being contemplated.
3. Beth Israel: Kevetrin is being reviewed for study as a treatment for melanoma
http://cellceutix.com/cellceutix-enters-into-...enal-cell-
carcinoma/#sthash.KAfktMfz.dpbs
Both above reported: http://cellceutix.com/wp-content/uploads/2012...0131-1.pdf
3. Kevetrin is being reviewed for study by MD Anderson as a potential new treatment for Lymphoma and Multiple Myeloma.
http://cellceutix.com/cellceutix-signs-materi...DT22l.dpbs
4.Cellceutix and Beth Israel are reviewing Kevetrin for study as a treatment for Retinoblastoma. CTIX believes that retinoblastoma would make an excellent candidate for a phase 2/3 trial once our present phase 1 trial is completed. It would qualify for a number of FDA programs (Orphan, Fast Track and Breakthrough) that can exponentially shrink development time, should clinical data support the current research. - See more at: http://cellceutix.com/cellceutix-plans-for-fu...xKFTM.dpuf
Tempered view huh.... Varies month to month.... History says it all.
georgejjl Saturday, 04/05/14 05:03:15 PM
Re: None
